Marathon Asset Management is a global investment manager specializing in credit and fixed income markets. The firm focuses on a variety of investment strategies, including private credit, direct lending, opportunistic credit, asset-based lending, and various forms of finance such as transportation, healthcare, and real estate. Marathon typically participates in private equity, post-IPO debt and equity rounds, and debt financing, managing a diverse portfolio of investment programs.
Notable portfolio companies include ADMA Biologics, Avenger Flight Group, Baudax Bio, Dermavant Sciences, Healogics, and Workhorse Group. Marathon's key partners and decision-makers bring extensive experience from leading financial institutions. The firm's investment philosophy emphasizes opportunistic investing and value creation through active management. Marathon also offers unique value-add services such as tailored financing solutions and strategic advisory to support the growth and success of its portfolio companies.
Portfolio Snapshot
Observed round participation, including acquisitions and grants. Current holdings, investor exits, and write-offs are not established.
Top Investment Stages
Marathon Venture Partners

Medalist Partners

Madryn Asset Management
madrynlp.com

MidOcean Partners

Amergin Asset Management
amerginam.com

Serengeti Asset Management
serengeti-am.com

Marshall Wace
mwam.com

Churchill Asset Management
churchillam.com

Arena Investors
arenaco.com
Arbour Lane Capital Management

Mount Logan Capital

ArrowMark Partners

Marlin Equity Partners
marlinequity.com
A&M Capital Partners
a-mcapital.com

Davidson Kempner Capital Management
Maranon Capital
maranoncapital.com

Hamilton Lane
hamiltonlane.com

Spring Mountain Capital

Madison Avenue Partners

Pinpoint Asset Management
pinpointfund.com